CVS Health Corporation (BMV:CVS)
Mexico · Delayed Price · Currency is MXN 1,306.35
+3.24 (0.25%)
At close: Feb 9, 2026
CVS Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,768 | 4,614 | 8,344 | 4,311 | 8,001 |
Depreciation & Amortization | 4,606 | 4,597 | 4,366 | 4,224 | 4,486 |
Loss (Gain) From Sale of Assets | -247 | - | 349 | 2,058 | - |
Asset Writedown & Restructuring Costs | 5,725 | 840 | 152 | - | 1,789 |
Stock-Based Compensation | 535 | 540 | 588 | 447 | 484 |
Other Operating Activities | -274 | -1,593 | -388 | -1,681 | -352 |
Change in Accounts Receivable | -3,498 | -1,301 | -6,260 | -2,971 | -2,703 |
Change in Inventory | -1,267 | -102 | 1,233 | -1,435 | 735 |
Change in Accounts Payable | 3,855 | 2,335 | 3,618 | 4,260 | 2,898 |
Change in Other Net Operating Assets | -564 | -823 | 1,424 | 6,964 | 2,927 |
Operating Cash Flow | 10,639 | 9,107 | 13,426 | 16,177 | 18,265 |
Operating Cash Flow Growth | 16.82% | -32.17% | -17.01% | -11.43% | 15.13% |
Capital Expenditures | -2,832 | -2,781 | -3,031 | -2,727 | -2,520 |
Cash Acquisitions | -436 | -95 | -16,612 | -139 | -146 |
Divestitures | - | - | - | -1,249 | - |
Investment in Securities | -2,629 | -4,838 | -1,314 | -1,017 | -2,717 |
Other Investing Activities | 26 | 101 | 68 | 85 | 122 |
Investing Cash Flow | -5,871 | -7,613 | -20,889 | -5,047 | -5,261 |
Short-Term Debt Issued | - | 1,919 | 5,200 | - | - |
Long-Term Debt Issued | 3,969 | 7,913 | 10,898 | - | 987 |
Total Debt Issued | 3,969 | 9,832 | 16,098 | - | 987 |
Short-Term Debt Repaid | -2,119 | - | -5,000 | - | - |
Long-Term Debt Repaid | -3,629 | -4,773 | -3,166 | -4,211 | -10,254 |
Total Debt Repaid | -5,748 | -4,773 | -8,166 | -4,211 | -10,254 |
Net Debt Issued (Repaid) | -1,779 | 5,059 | 7,932 | -4,211 | -9,267 |
Issuance of Common Stock | 394 | 361 | 277 | 551 | 549 |
Repurchase of Common Stock | -158 | -3,208 | -2,193 | -3,870 | -168 |
Common Dividends Paid | -3,397 | -3,373 | -3,132 | -2,907 | -2,625 |
Other Financing Activities | - | 26 | -201 | -79 | 155 |
Financing Cash Flow | -4,940 | -1,135 | 2,683 | -10,516 | -11,356 |
Net Cash Flow | -172 | 359 | -4,780 | 614 | 1,648 |
Free Cash Flow | 7,807 | 6,326 | 10,395 | 13,450 | 15,745 |
Free Cash Flow Growth | 23.41% | -39.14% | -22.71% | -14.58% | 17.26% |
Free Cash Flow Margin | 1.95% | 1.71% | 2.92% | 4.18% | 5.41% |
Free Cash Flow Per Share | 6.14 | 5.01 | 8.06 | 10.17 | 11.85 |
Cash Interest Paid | 2,991 | 2,909 | 2,418 | 2,239 | 2,469 |
Cash Income Tax Paid | 2,166 | 1,703 | 3,524 | 4,116 | 3,195 |
Levered Free Cash Flow | 5,930 | 6,909 | 11,075 | 11,935 | 14,783 |
Unlevered Free Cash Flow | 7,879 | 8,758 | 12,737 | 13,365 | 16,347 |
Change in Working Capital | -1,474 | 109 | 15 | 6,818 | 3,857 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.